Non-Invasive Prenatal Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022, the non-invasive prenatal testing market was valued at USD 613.0 Mn in 2015, and is expected to reach USD 1,939.9 Mn by 2022, expanding at a CAGR of 17.9% from 2016 to 2022.
Browse Full Report Visit - http://www.acutemarketreports.com/report/non-invasive-prenatal-testing-market-report
Market Insights
The global non-invasive prenatal tests (NIPT) market is experiencing a double-digit growth facilitated by market drivers such as rise in average maternity age, growing incidence of chromosomal abnormalities that demand early and non-invasive detection. Other major factor that aids to the growth of this market is rise in healthcare expenditure.
Non-invasive prenatal testing is defined as a highly sensitive screening process that assists in detecting chromosomal abnormalities in the fetus during pregnancy. Some of such chromosomal abnormal abilities that can be detected through NIPT are Down syndrome, Patau syndrome, Edwards’ syndrome and Turner syndrome.
Among the available NIPT tests, the MaternitT21 test is the largest segment and it is anticipated that its dominance will continue through 2022. It was the first test to receive approval for detection of Trisomy 21 in 2011. Other chromosomal abnormalities that could be detected with MaternitT21 are Wolf-Hirschhorn syndrome, DiGeorge syndrome, Langer-Giedion syndrome, 1q36 deletion syndrome and Jaconsen syndrome. MaterniT21 used cfDNA and parallel sequencing technology and delivers results in a 5 day period.
North America is the largest market for non-invasive prenatal testing. Emerging markets of Asia-Pacific and Latin America are growing at a significant growth rate, attributed by the growing awareness about chromosomal abnormalities, their prevention, growing population of late maternity age, and rapid development of healthcare infrastructure. However, ethical concerns associated with such tests is the most prominent market restraint.
The major players engaged in the global noninvasive prenatal testing market are LifeCodexx AG, Illumina, Inc., Sequenom, Inc. LABCORP, Natera, Inc. and others.
The global non-invasive prenatal tests (NIPT) market is experiencing a double-digit growth facilitated by market drivers such as rise in average maternity age, growing incidence of chromosomal abnormalities that demand early and non-invasive detection. Other major factor that aids to the growth of this market is rise in healthcare expenditure.
Non-invasive prenatal testing is defined as a highly sensitive screening process that assists in detecting chromosomal abnormalities in the fetus during pregnancy. Some of such chromosomal abnormal abilities that can be detected through NIPT are Down syndrome, Patau syndrome, Edwards’ syndrome and Turner syndrome.
Among the available NIPT tests, the MaternitT21 test is the largest segment and it is anticipated that its dominance will continue through 2022. It was the first test to receive approval for detection of Trisomy 21 in 2011. Other chromosomal abnormalities that could be detected with MaternitT21 are Wolf-Hirschhorn syndrome, DiGeorge syndrome, Langer-Giedion syndrome, 1q36 deletion syndrome and Jaconsen syndrome. MaterniT21 used cfDNA and parallel sequencing technology and delivers results in a 5 day period.
North America is the largest market for non-invasive prenatal testing. Emerging markets of Asia-Pacific and Latin America are growing at a significant growth rate, attributed by the growing awareness about chromosomal abnormalities, their prevention, growing population of late maternity age, and rapid development of healthcare infrastructure. However, ethical concerns associated with such tests is the most prominent market restraint.
The major players engaged in the global noninvasive prenatal testing market are LifeCodexx AG, Illumina, Inc., Sequenom, Inc. LABCORP, Natera, Inc. and others.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/pharmaceutical-market
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Non-Invasive Prenatal Testing Market, by Products, 2015 (USD Mn)
2.2 Non-Invasive Prenatal Testing Market Share, by Geography, 2015 (Value %)
2.1 Non-Invasive Prenatal Testing Market, by Products, 2015 (USD Mn)
2.2 Non-Invasive Prenatal Testing Market Share, by Geography, 2015 (Value %)
Chapter 3 Non-Invasive Prenatal Testing Market: Market Dynamics and Outlook
3.1 Introduction
3.2 Major Commercial Events
3.3 Drivers
3.4 Challenges
3.5 Opportunities
3.6 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players
3.1 Introduction
3.2 Major Commercial Events
3.3 Drivers
3.4 Challenges
3.5 Opportunities
3.6 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players
Chapter 4 Global Non-Invasive Prenatal Testing Market Analysis, by Products
4.1 Preface
4.2 MaterniT21 PLUS
4.3 BambniTest
4.4 informaSeq Prenatal Test
4.5 Harmony Prenatal Test
4.6 Non-invasive Fetal Trisomy (NIFTY) Test
4.7 verifi
4.8 PrenaTest
4.9 Panorama Test
4.10 VisibiliT Test
4.1 Preface
4.2 MaterniT21 PLUS
4.3 BambniTest
4.4 informaSeq Prenatal Test
4.5 Harmony Prenatal Test
4.6 Non-invasive Fetal Trisomy (NIFTY) Test
4.7 verifi
4.8 PrenaTest
4.9 Panorama Test
4.10 VisibiliT Test
Chapter 5 Global Non-Invasive Prenatal Testing Market, by Geography
5.1 Preface
5.2 North America
5.2.1 U.S.
5.2.2 Canada
5.3 Europe
5.3.1 U.K.
5.3.2 Germany
5.3.3 Rest of Europe
5.4 Asia-Pacific
5.4.1 Japan
5.4.2 China
5.4.3 Rest of Asia-Pacific
5.5 Middle East and Africa (MEA)
5.6 Latin America
5.1 Preface
5.2 North America
5.2.1 U.S.
5.2.2 Canada
5.3 Europe
5.3.1 U.K.
5.3.2 Germany
5.3.3 Rest of Europe
5.4 Asia-Pacific
5.4.1 Japan
5.4.2 China
5.4.3 Rest of Asia-Pacific
5.5 Middle East and Africa (MEA)
5.6 Latin America
To Get Complete Report @ http://www.acutemarketreports.com/report/non-invasive-prenatal-testing-market-report
Chapter 6 Company Profiles
6.1 Ariosa Diagnostics, Inc.
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Positions/Portfolio
6.1.4 News Coverage
6.2 Berry Genomics Co., Ltd.
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Positions/Portfolio
6.2.4 News Coverage
6.3 BGI Diagnostics
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Positions/Portfolio
6.3.4 News Coverage
6.4 Illumina, Inc.
6.1 Ariosa Diagnostics, Inc.
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Positions/Portfolio
6.1.4 News Coverage
6.2 Berry Genomics Co., Ltd.
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Positions/Portfolio
6.2.4 News Coverage
6.3 BGI Diagnostics
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Positions/Portfolio
6.3.4 News Coverage
6.4 Illumina, Inc.
Latest Reports :
http://www.acutemarketreports.com/report/3d-bioprinters-market
http://www.acutemarketreports.com/report/3d-bioprinters-market
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
Our Blog :- http://www.pdfdevices.com/
